Related Experiment Video
Updated: Jun 11, 2025

06:05
Author Spotlight: Enhancing Bone Regeneration with Vascularized Artificial Cartilage Integration
Published on: July 14, 2023
946
Smart Implantable Hydrogel for Large Segmental Bone Regeneration
Menghan Li1,2, Haiping Wu3, Ke Gao2
1The Center for Clinical Molecular Medical Detection, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, P. R. China.
Advanced Healthcare Materials
|September 30, 2024
Summary
This study introduces a smart hydrogel implant (PDS-DC) that promotes bone regeneration by mimicking natural healing. It delivers drugs sequentially to enhance vascularization and bone formation for better bone defect repair.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Tissue Engineering
Background:
- Large segmental bone defects present a significant clinical challenge, often resulting in nonunion and impaired function.
- Current treatments struggle to effectively address the complex biological processes of bone healing, namely vascularization and osteogenesis.
Purpose of the Study:
- To develop a smart implantable hydrogel (PDS-DC) capable of promoting bone regeneration by mimicking the natural sequence of vascularization followed by osteogenesis.
- To engineer a hydrogel with tunable mechanical properties, controllable degradation, and timed drug release to match distinct phases of bone healing.
Main Methods:
- Fabrication of the PDS-DC hydrogel using polyacrylamide, polydopamine, and silk fibroin for enhanced mechanical properties and adhesion.
- Regulation of in vivo degradation rates by adjusting the cross-linking agent mixing ratio.
- Loading of desferrioxamine (DFO) for rapid release and CaCO3-mineralized ZIF-90 loaded bone morphogenetic protein-2 (BMP-2) for sustained release to sequentially stimulate angiogenesis and osteogenesis.
Main Results:
- The PDS-DC hydrogel demonstrated superior interfacial adhesion, toughness, and mechanical stiffness.
- Tunable degradation rates were achieved by modifying the cross-linking ratio, allowing adaptation to different bone healing requirements.
- Sequential release of DFO and BMP-2 was confirmed, effectively mimicking the 'vascularization then osteogenesis' principle.
- In vitro and in vivo studies validated the hydrogel's efficacy in promoting high-quality bone generation and adapting to defect-specific needs.
Conclusions:
- The PDS-DC hydrogel represents a novel smart biomaterial for enhanced bone regeneration.
- Its ability to control degradation and drug release timing offers a promising strategy for treating large segmental bone defects.
- This approach effectively aligns with the intrinsic logic of bone repair, paving the way for improved clinical outcomes.

